RPRX Stock Analysis: Buy, Sell, or Hold?
RPRX - Royalty Pharma plc Class A Ordinary Shares
$63.75
1.60 (2.57%)
▲
5d:
+6.93%
30d:
+10.58%
90d:
+8.36%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
11d
Get Alerted When RPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RPRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RPRX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$73.04
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$45.36
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RPRX is currently trading at $63.75, which is considered extended relative to its 30-day fair value range of $56.82 to $60.38. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.0) compared to its historical average (9.2). At these levels, the market is pricing in 6.0% annual earnings growth.
Technical Outlook: Technically, RPRX is in a strong uptrend. The price is approaching resistance at $63.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RPRX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RPRX is in a strong uptrend. The price is approaching resistance at $63.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RPRX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$56.82 -
$60.38
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.4%
Protect Your Profits
RPRX is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.6% above its trading range)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($65.38)
- BULLISH: Expecting earnings turnaround to 6.0% growth with 16.5% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$56.82 -
$60.38
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$55.72
Resistance Level
$63.84
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.99
Wall Street Target
$65.38
(+2.5%)
Revenue Growth (YoY)
16.5%
Earnings Growth (YoY)
-46.3%
Profit Margin
32.0%
Valuation Premium vs History
+6.0% premium
PE vs Historical
11.0 vs 9.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$67.58
(+6%)
2-Year Target
$71.63
(+12%)
3-Year Target
$75.93
(+19%)
3-Yr Target (if PE normalizes)
(PE: 11→9)
PE COMPRESSION
$63.54
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.0%)
$149.04
(+134%)
Base:
(SPY PE: 11.0, Growth: 9.0%)
$82.50
(+29%)
Bear:
(PE: 9.2, Growth: 9.0%)
$69.04
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 33.06 | Current EPS (TTM): $1.88
Bull Case
$136.73
(+115%)
Analyst growth 100.0%, PE expands to 36.4
Base Case
$124.30
(+95%)
Market implied 100.0%, PE stable at 33.1
Bear Case
$42.26
(-34%)
Severe decline -20.0%, PE contracts to 28.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 56 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 49 HOLD |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 69 BUY |
Advanced RPRX Option Strategies
Professional options setups generated by AI based on today's RPRX price and gamma walls.
